NT-proBNP in patients after acute coronary syndrome with ST segment elevation subjected to early posthospitalization cardiologic rehabilitation

Archives of Medical Science

Volumn 2, Issue 4, 2006, Pages 262-267

  Irzmanski, Robert ^a   Piechota, Mariusz ^a   Barylski, Marcin ^a   Banach, Maciej ^a   Kowalski, Jan ^a   Serwa Stȩpień, Ewa ^a   Drozdz, Jarosław ^a   Pawlicki, Lucjan ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acute coronary syndrome; Cardiologic rehabilitation; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; EXERCISE; HEART INFARCTION; HEART REHABILITATION; HOSPITALIZATION; HUMAN; MALE; RISK ASSESSMENT; SEX DIFFERENCE; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 33846285411     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Stein BC, Levin RI. Natriuretic peptides: Physiology, therapeutic potential and risk stratification in ischemic heart disease. Am Heart J 1998; 135: 914-23.
2. Nakao K, Ogawa Y, Suga S, Imura H, et al. Molecular biology and biochemistry of the natriuretic peptide system II: natriuretic peptide receptors. J Hypertens 1992; 10: 1111-4.
3. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. et al. Renal, endocrine and hemodynamic effect of human brain natriuretic peptide in normal man. J Clin Endocr Metab 1993; 76: 91-6.
4. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, et al. The prognostic value of fatype natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21.
5. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 1587-93.
6. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein and B-type natriuretic peptide. Circulation 2002; 105: 1760-3.
7. Verani MS, Hartung GH, Hoepfel-Harris J, Welton DE, Pratt CM, Miller RR. Effects of exercise training on left performance and myocardial perfusion in patients with coronary artery disease. Am J Cardiol 1981; 47: 797-803.
8. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342: 454-60.
9. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988; 78: 506-15
10. Coats AJ, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119-31.
11. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial JAMA 2000; 283: 3095-101.
12. Balady GJ, Ades PA, Comoss P, Limacher M, Pina IL, Southard D, et al. Core components of cardiac rehabilitation/secondary prevention programs; a statement for healthcare professional from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. Circulation 2000; 102: 1069-73.
13. Opie LH, King LM. Glukose and glycogen utilization in myocardial ischaemia changes in metabolism and consequences for the myocyte. Moll Cell Biochem 1998; 180: 3-26.
14. Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in post-ichaemic myocardium. Ore Res 1992; 71: 567-76.
15. Ferrari R, Pedersini P, Bongrazio M, Gaia G, Bernocchi P, Di Lisa F, et al. Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion. Basic Res Cardiol 1993; 88: 495-512.
16. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in urban population. Lancet 1997; 350: 829-33.
17. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, et al. Heart contains an active 5′-AMP-activated protein kinase that is involved in the regulation of fatty acid oxidation. Circulation 1996; 92: 1771-7.
18. Kowalski J, Kosmider M, Baj Z et al. Plasma concentrations of selected cytokines in patients with unstable angina pectoris during percutaneous transluminal coronary angioplasty (PTCA). Int Rev Allergol Clin Immunol 1997; 3:139-141.
19. Gao WD, Atar D, Backx PH, Marban E. Relationship between intracellular calcium and contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 1995; 76: 1036-48.
20. Voci P, Mariano E, Pizzuto F, Puddu PE, Romeo F. Coronary recanalization in anterior myocardial infarction. The open perforator hypothesis. J Am Coll Cardiol 2002; 40: 1205-13.
21. Bazzino O, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J; PACS group of investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non ST-elevation acute coronary syndromes. Eur Heart J 2004; 25: 859-66.
22. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al.; Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 2003; 107: 1278-83.
23. Giannuzzi P, Temporelli PL, Corra U, Gattone M, Giordano A, Tavazzi L Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation 1997; 96: 1790-7.
24. Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 20: 1797-805.
25. Ades PA, Maloney A, Savage P, Carhart RLJr. Determinants of physical functioning in coronary patients: response to cardiac rehabilitation. Arch Intern Med 1999; 159: 2357-60.
26. Ito N, Nitta Y, Ohtani H, Ooshima A, Isoyama S. Remodelling of microvessels by coronary hypertension or cardiac hypertrophy. J Mol Cell Cardiol 1994; 26: 49-59.
27. Niebauer J, Hambrecht R, Velich T, Hauer K, Marburger C, Kalberer B, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation 1997; 96: 2534-41.